Exploring the therapeutic potential of NCX1 in hematological cancers; integration of molecular docking, bioinformatics approaches, and experimental validation.
- DOI
- 10.1016/j.bbrc.2026.154322
- Published
- 2026 Sep 17
- Container
- Biochemical and biophysical research communications
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bbrc.2026.154322,
title = {Exploring the therapeutic potential of NCX1 in hematological cancers; integration of molecular docking, bioinformatics approaches, and experimental validation.},
author = {Misir S and Yaman SO and Petrović N and Cakmak I and Šami A and Jovanović B and Srdić-Rajić T and Stanojković T and Jovanović-Ćupić S and Hepokur C and Cimbek A and Obeid MA and Aliyazicioglu Y},
year = {2026},
journal = {Biochemical and biophysical research communications},
doi = {10.1016/j.bbrc.2026.154322},
url = {https://doi.org/10.1016/j.bbrc.2026.154322}
}RIS
TY - JOUR TI - Exploring the therapeutic potential of NCX1 in hematological cancers; integration of molecular docking, bioinformatics approaches, and experimental validation. AU - Misir S AU - Yaman SO AU - Petrović N AU - Cakmak I AU - Šami A AU - Jovanović B AU - Srdić-Rajić T AU - Stanojković T AU - Jovanović-Ćupić S AU - Hepokur C AU - Cimbek A AU - Obeid MA AU - Aliyazicioglu Y PY - 2026 JO - Biochemical and biophysical research communications DO - 10.1016/j.bbrc.2026.154322 UR - https://doi.org/10.1016/j.bbrc.2026.154322 ER -
APA
S, M., SO, Y., N, P., I, C., A, Š., B, J., T, S., T, S., S, J., C, H., A, C., MA, O., & Y, A. (2026). Exploring the therapeutic potential of NCX1 in hematological cancers; integration of molecular docking, bioinformatics approaches, and experimental validation.. Biochemical and biophysical research communications. https://doi.org/10.1016/j.bbrc.2026.154322
Source records
- pubmed · retrieved 2026-09-25T23:32:25.093Z
- europe-pmc · retrieved 2026-09-25T23:32:25.108Z